326 related articles for article (PubMed ID: 35077555)
1. Barriers and enablers to deprescribing in long-term care facilities: a 'best-fit' framework synthesis of the qualitative evidence.
Heinrich CH; Hurley E; McCarthy S; McHugh S; Donovan MD
Age Ageing; 2022 Jan; 51(1):. PubMed ID: 35077555
[TBL] [Abstract][Full Text] [Related]
2. Barriers and enablers to deprescribing in long-term care: A qualitative investigation into the opinions of healthcare professionals in Ireland.
Heinrich CH; McHugh S; McCarthy S; Donovan MD
PLoS One; 2022; 17(12):e0274552. PubMed ID: 36520798
[TBL] [Abstract][Full Text] [Related]
3. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
Alharthi M; Wright D; Scott S; Birt L
Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
[TBL] [Abstract][Full Text] [Related]
4. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
Palagyi A; Keay L; Harper J; Potter J; Lindley RI
BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
[TBL] [Abstract][Full Text] [Related]
5. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
Evrard P; Pétein C; Beuscart JB; Spinewine A
Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
[TBL] [Abstract][Full Text] [Related]
6. Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists.
Scott S; Twigg MJ; Clark A; Farrow C; May H; Patel M; Taylor J; Wright DJ; Bhattacharya D
Age Ageing; 2019 Dec; 49(1):102-110. PubMed ID: 31711097
[TBL] [Abstract][Full Text] [Related]
7. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
[TBL] [Abstract][Full Text] [Related]
8. Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.
Tangiisuran B; Rajendran V; Sha'aban A; Daud NAA; Nawi SNM
Int J Clin Pharm; 2022 Feb; 44(1):201-213. PubMed ID: 34642869
[TBL] [Abstract][Full Text] [Related]
9. Healthcare professionals' perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework.
Alwidyan T; McCorry NK; Parsons C
Int J Pharm Pract; 2023 May; 31(3):305-313. PubMed ID: 36866441
[TBL] [Abstract][Full Text] [Related]
10. Exploration of home care nurse's experiences in deprescribing of medications: a qualitative descriptive study.
Sun W; Tahsin F; Barakat-Haddad C; Turner JP; Haughian CR; Abbass-Dick J
BMJ Open; 2019 May; 9(5):e025606. PubMed ID: 31129579
[TBL] [Abstract][Full Text] [Related]
11. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
[TBL] [Abstract][Full Text] [Related]
12. Barriers and enablers to deprescribing of older adults and their caregivers: a systematic review and meta-synthesis.
Bolt J; Abdoulrezzak R; Inglis C
Eur Geriatr Med; 2023 Dec; 14(6):1211-1222. PubMed ID: 37874489
[TBL] [Abstract][Full Text] [Related]
13. Barriers and enablers to deprescribing in people with a life-limiting disease: A systematic review.
Paque K; Vander Stichele R; Elseviers M; Pardon K; Dilles T; Deliens L; Christiaens T
Palliat Med; 2019 Jan; 33(1):37-48. PubMed ID: 30229704
[TBL] [Abstract][Full Text] [Related]
14. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
[TBL] [Abstract][Full Text] [Related]
16. Implementation considerations of deprescribing interventions: A scoping review.
Wang J; Shen JY; Conwell Y; Podsiadly EJ; Caprio TV; Nathan K; Yu F; Ramsdale EE; Fick DM; Mixon AS; Simmons SF
J Intern Med; 2024 Apr; 295(4):436-507. PubMed ID: 36524602
[TBL] [Abstract][Full Text] [Related]
17. Potentially inappropriate medication and attitudes of older adults towards deprescribing.
Achterhof AB; Rozsnyai Z; Reeve E; Jungo KT; Floriani C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
PLoS One; 2020; 15(10):e0240463. PubMed ID: 33104695
[TBL] [Abstract][Full Text] [Related]
18. Barriers and enablers of older adults initiating a deprescribing conversation.
Ailabouni NJ; Rebecca Weir K; Reeve E; Turner JT; Wilson Norton J; Gray SL
Patient Educ Couns; 2022 Mar; 105(3):615-624. PubMed ID: 34183219
[TBL] [Abstract][Full Text] [Related]
19. Barriers and Enablers for Deprescribing Glucose-Lowering Treatment in Older Adults: A Systematic Review.
Mellot M; Jawal L; Morel T; Fournier JP; Tubach F; Cadwallader JS; Christiaens A; Zerah L
J Am Med Dir Assoc; 2024 Mar; 25(3):439-447.e18. PubMed ID: 38237904
[TBL] [Abstract][Full Text] [Related]
20. Considerations, barriers and enablers of deprescribing among healthcare professionals in Ogun State, Southwest, Nigeria: a cross-sectional survey.
Saka SA; Osineye TR
BMC Health Serv Res; 2024 May; 24(1):661. PubMed ID: 38789975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
